Figure 3.

Distribution of Ki-67 labelling values for human and CAIA evaluation (data are show only for the 223 cases immunostained with SP6 MAb).

Fasanella et al. Diagnostic Pathology 2011 6(Suppl 1):S7   doi:10.1186/1746-1596-6-S1-S7